Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, indicating a minor update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-05-17T10:20:20.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s footer/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend or display version change rather than a change to the clinical study details.
    Difference
    0.0%
    Check dated 2026-04-25T17:47:34.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:21:53.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added the MeSH term 'Cutaneous neuroendocrine carcinoma' and updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-28T01:52:02.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:41:22.000Z thumbnail image
  9. Check
    110 days ago
    Change Detected
    Summary
    Gastric cancer was added to the list of conditions for the study, broadening the potential population the page pertains to. A new Genetic and Rare Diseases Information Center resource was added under Resources, and the site revision banner updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-13T13:41:29.000Z thumbnail image

Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.